Drugs / K-134
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00783081 | Nov 2008 → Jul 2010 | intermittent vascular claudication | Kowa Research Institute, Inc. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | K-134 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00783081 ↗ |
| Known as | OPC-33509 | ChEMBL registry synonym — accepted as the source's own label CHEMBL284838 ↗ |
| Action | Inhibit | “K-134 is a selective PDE 3 inhibitor being developed as a potential treatment for claudication.” PMID 21612611 ↗ May 2011 |
| Modality | Small molecule | “K-134 is a selective PDE 3 inhibitor being developed as a potential treatment for claudication.” PMID 21612611 ↗ May 2011 |